Results 51 to 60 of about 10,148,262 (306)

Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi   +9 more
wiley   +1 more source

Palestinske flyktningers kår etter Nahr al-Bared

open access: yesBabylon, 2016
Raseringen av Nahr al-Bared har gjort en tidel av de fattige og rettighetsløse palestinske flyktningene i Libanon hjemløse. Det vil i beste fall ta flere år før de kan flytte hjem.
Åge A. Tiltnes
doaj   +1 more source

Informal and formal care among persons with dementia immediately before nursing home admission

open access: yesBMC Geriatrics, 2020
Background Dementia is a care intensive disease, especially in the later stages, implying in many cases a substantial carer burden. This study assesses the use of formal and informal care resources among persons with dementia during the last month before
Arnt Egil Ydstebø   +4 more
doaj   +1 more source

Prognosis of Long‐Term Continuous Renal Replacement Therapy and the Impact of Combined Continuous Intravenous Sodium Infusion Therapy

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Patients requiring long‐term continuous renal replacement therapy (CRRT) generally have poor prognoses. This study evaluated whether adding continuous intravenous sodium infusion (cIVNa) is associated with improved hemodynamics and outcomes in patients undergoing long‐term CRRT for ≥ 7 days.
Akinori Yamaguchi   +6 more
wiley   +1 more source

Age Poll, April 1974

open access: yes, 2018
The Age Poll was first conducted in March 1971 by the Australian Sales Research Bureau Pty. Ltd. before switching to Irving Saulwick and Associates in April 1975. Conducted in February 1974 this 'Age Poll' is the twelfth in the Age Poll series.
The Age
core   +1 more source

A novel proteomic signature of osteoclast differentiation unveils the deubiquitinase UCHL1 as a necessary osteoclastogenic driver

open access: yesScientific Reports
Bone destruction, a major source of morbidity, is mediated by heightened differentiation and activity of osteoclasts (OC), highly specialized multinucleated myeloid cells endowed with unique bone-resorptive capacity.
Maria Materozzi   +8 more
doaj   +1 more source

Enteropathogenic E. coli shows delayed attachment and host response in human jejunum organoid‐derived monolayers compared to HeLa cells

open access: yesFEBS Letters, EarlyView.
Enteropathogenic E. coli (EPEC) infects the human intestinal epithelium, resulting in severe illness and diarrhoea. In this study, we compared the infection of cancer‐derived cell lines with human organoid‐derived models of the small intestine. We observed a delayed in attachment, inflammation and cell death on primary cells, indicating that host ...
Mastura Neyazi   +5 more
wiley   +1 more source

Age Poll, November 1972

open access: yes, 2018
The Age Poll was first conducted in March 1971 by the Australian Sales Research Bureau Pty. Ltd. before switching to Irving Saulwick and Associates in April 1975. Conducted in November 1972 this 'Age Poll' is the eighth in the Age Poll series.
The Age
core   +1 more source

Performance of plasma p-tau217 for the detection of amyloid-β positivity in a memory clinic cohort using an electrochemiluminescence immunoassay

open access: yesAlzheimer’s Research & Therapy
Background Plasma p-tau217 has emerged as the most promising blood-based marker (BBM) for the detection of Alzheimer Disease (AD) pathology, yet few studies have evaluated plasma p-tau217 performance in memory clinic settings. We examined the performance
Adam H. Dyer   +24 more
doaj   +1 more source

Organoids in pediatric cancer research

open access: yesFEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

Home - About - Disclaimer - Privacy